EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expiration Date of Extemporaneous Pyrimethamine Formulations for Treating Congenital Toxoplasmosis: Physicochemical and Microbiological Evaluation

Renato Medeiros de Paula, Vitoria Beatriz Silva Santana, Marcelo Vítor de Paiva Amorim iD, Douglas Dourado, Éverton do Nascimento Alencar iD, Débora Araújo Othon de Aquino, Lourena Mafra Veríssimo iD

ACS Omega · 01.06.2026

DOI: 10.1021/acsomega.5c12714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 01.06.2026. Verfasst von Renato Medeiros de Paula und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande 59078-970, Brazil. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior, Pr?-Reitoria de Pesquisa, Universidade Federal do Rio Grande do Norte, N?cleo de Pesquisa em Alimentos e Medicamentos, Universidade Federal do Rio Grande do Norte.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the stability of extemporaneous pyrimethamine oral suspensions prepared from commercial tablets using 85% sucrose or 70% sorbitol as vehicles. A validated HPLC method was employed to quantify pyrimethamine and assess its chemical stability. Physicochemical parameters including macroscopic appearance, pH, particle size, and drug content were monitored for 90 days at 5 and 25 °C. Both formulations maintained acceptable pH values and pyrimethamine content within pharmacopeial limits. Particle size increased over time, likely due to aggregation, while appearance remained unchanged for up to 45 days. Microbiological assessments showed that microorganisms remained within acceptable limits, with no objectionable microorganisms detected. Overall, both suspensions demonstrated chemical and microbiological stability for up to 45 days (Suspension S) and 60 days (Suspension X) under both storage conditions. These results support the preparation of cost-effective pyrimethamine formulations for treating congenital toxoplasmosis in pediatric patients.

Autor:innen und Institutionen

  • Department of Pharmacy, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande 59078-970, Brazil.
  • University for International Integration of the Afro-Brazilian Lusophony (UNILAB), José Franco de Oliveira Street, Redenção, Ceará 62.790-970, Brazil.
  • College of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul 79070-900, Brazil.
  • Center for Food and Drug Research (NUPLAM), UFRN, Natal, Rio Grande 59078-900, Brazil.

ORCID-Profile: Marcelo Vítor de Paiva Amorim, Éverton do Nascimento Alencar, Lourena Mafra Veríssimo

Förderung

  • Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
  • Pr?-Reitoria de Pesquisa, Universidade Federal do Rio Grande do Norte
  • N?cleo de Pesquisa em Alimentos e Medicamentos, Universidade Federal do Rio Grande do Norte

Zitieren

APA

de Paula, R. M., Santana, V. B. S., Amorim, M. V. P., Dourado, D., Alencar, É. D. N., de Aquino, D. A. O., & Veríssimo, L. M. (2026). Expiration Date of Extemporaneous Pyrimethamine Formulations for Treating Congenital Toxoplasmosis: Physicochemical and Microbiological Evaluation. ACS Omega. https://doi.org/10.1021/acsomega.5c12714

Vancouver

de Paula RM, Santana VBS, Amorim MVP, Dourado D, Alencar ÉDN, de Aquino DAO, et al. Expiration Date of Extemporaneous Pyrimethamine Formulations for Treating Congenital Toxoplasmosis: Physicochemical and Microbiological Evaluation. ACS Omega. 2026. doi:10.1021/acsomega.5c12714

BibTeX
@article{dePaula2026,
  author = {de Paula, Renato Medeiros and Santana, Vitoria Beatriz Silva and Amorim, Marcelo Vítor de Paiva and Dourado, Douglas and Alencar, Éverton do Nascimento and de Aquino, Débora Araújo Othon and Veríssimo, Lourena Mafra},
  title = {Expiration Date of Extemporaneous Pyrimethamine Formulations for Treating Congenital Toxoplasmosis: Physicochemical and Microbiological Evaluation},
  journal = {ACS Omega},
  year = {2026},
  doi = {10.1021/acsomega.5c12714}
}
Kostenlos starten →